Compare HAS & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HAS | RVTY |
|---|---|---|
| Founded | 1923 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1B | 9.9B |
| IPO Year | N/A | N/A |
| Metric | HAS | RVTY |
|---|---|---|
| Price | $82.65 | $104.38 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 13 |
| Target Price | $88.55 | ★ $112.92 |
| AVG Volume (30 Days) | ★ 1.8M | 1.7M |
| Earning Date | 10-23-2025 | 10-27-2025 |
| Dividend Yield | ★ 3.39% | 0.27% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.99 |
| Revenue | ★ $4,357,000,000.00 | $2,813,367,000.00 |
| Revenue This Year | $10.39 | $5.37 |
| Revenue Next Year | $6.29 | $3.07 |
| P/E Ratio | ★ N/A | $53.56 |
| Revenue Growth | 0.79 | ★ 3.37 |
| 52 Week Low | $49.00 | $81.36 |
| 52 Week High | $83.40 | $128.29 |
| Indicator | HAS | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 71.40 | 68.48 |
| Support Level | $76.61 | $89.65 |
| Resistance Level | $83.40 | $106.52 |
| Average True Range (ATR) | 1.70 | 2.79 |
| MACD | 0.54 | 1.32 |
| Stochastic Oscillator | 91.42 | 86.96 |
Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Nerf, and Magic: The Gathering. The firm acquired EOne in 2019, bolting on popular family properties like Peppa Pig and PJ Masks, and since has divested noncore lines from the tie-up. Furthermore, the addition of Dungeons & Dragons Beyond in 2022, offers the firm access to 19 million digital tabletop players.
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.